The Ebola scare combined with the precautions we take (sealing the room, monitoring for leaks, scrubbers) may override any concerns EPA may have about O3 leaking into the hospital environment. However, it does worry me that this could be a showstopper.
I really think MZEI needs more demo units that can be used and tested in multiple environments. I've sold a lot of technology over the last 28 years. As Geoffrey Moore very accurately explains in his book "Crossing the Chasm" http://ow.ly/D3rHi, you need some innovators to try the product early on and be able to act as references to the larger group of early adopters who come after them.
I'm beginning to believe that many of the people I've been considering naysayers on this board are right - IMO, MZEI needs to hire a management team that is focused on implementing the product in multiple locations. And then, driving sales results.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.